Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
November 27th, 2008
DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) announced the launch of BCtect(TM), a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature identified by DiaGenic using a custom TaqMan(R) Array manufactured for DiaGenic by Applied Biosystems. India was chosen as the first country for the introduction of BCtect(TM) after successful completion of a large study in the country. The DiaGenic BCtect(TM) test addresses a significant medical need in India, where breast cancer is the second leading cause of death among women. The lack of a coordinated national screening program means that breast cancer is...
Source: Women's Health Weekly (2008-11-27)
|
